Almost every claim made for a topical peptide rests on one question that rarely gets asked directly: does the molecule actually get past the outermost layer of skin? Collagen synthesis happens in the dermis. If a peptide sits on top of the stratum corneum and never crosses it, nothing measured in a petri dish of fibroblasts is relevant to what a serum does on your face. GHK-Cu has been studied on this specific point, and the answer is more interesting, and more contested, than either the marketing or the skeptics suggest.
This article covers GHK-Cu as a cosmetic ingredient. It is not medical advice, and nothing here has been evaluated by the FDA.
Key Takeaways
- Two diffusion-cell studies found that GHK and its copper complexes do migrate across membranes built to model the stratum corneum, and that free copper ions without a peptide carrier largely do not [1] [2].
- Permeability increased as pH increased in that model system, meaning formulation pH is not a cosmetic detail but a variable that changed how much crossed [1].
- All of that data comes from artificial model membranes in laboratory diffusion cells, not from human skin measured in a living person.
- Two 2025 reviews read the same body of evidence differently: one concludes GHK-Cu is “relatively skin permeable” [3], the other describes “limited permeation through the lipophilic stratum corneum” [4].
- The same 2025 review that leans positive on permeability also reports a “surprising absence of clinical studies” using GHK-Cu in the anti-wrinkle products it is sold in [3].
Why Penetration Is the Question That Decides Everything Else
The stratum corneum is a lipid-rich barrier engineered to keep water in and foreign molecules out, and it is very good at its job. Molecules that cross it easily tend to be small and fat-soluble. GHK-Cu is neither: it is a hydrophilic tripeptide complex with high aqueous solubility and a low partition coefficient, which is chemistry-speak for a molecule that prefers water to lipid and therefore has no natural affinity for the barrier it needs to cross [3]. That is the core tension in the entire copper peptide category. The mechanistic work is genuinely strong: a foundational 1988 study showed the GHK-copper complex directly stimulated collagen synthesis in cultured human fibroblasts [5]. But fibroblasts in culture are already bathed in the compound. Getting the compound to fibroblasts that sit under an intact barrier is a separate problem, and it is the problem that determines whether a serum does anything at all.
What the Diffusion-Cell Studies Measured
Two studies from the same Warsaw University of Technology group addressed this directly. The first, published in Talanta in 2007, used a Flynn diffusion cell fitted with a liposome membrane as a stand-in for the stratum corneum, then used mass spectrometry to identify which copper species actually made it across [1]. The finding was specific: only the tripeptide GHK and its copper complexes, GHK-Cu and the two-to-one (GHK)2-Cu form, were able to migrate through the model membrane. That is a meaningful result, because it says the peptide is not incidental packaging. It is what makes copper transportable across a lipid barrier at all.
The follow-up study, published in the Journal of Cosmetic Science in 2008, used a Franz diffusion cell with liquid crystalline systems chosen for physicochemical similarity to the intercellular cement of the stratum corneum [2]. It reached a consistent conclusion: copper complexes permeated through membranes modeling the horny lipid layer, and the identity of the peptide influenced the dynamics of copper ion diffusion. The authors also noted something worth repeating, that transport of copper-tripeptide complexes across the stratum corneum had “received very little attention in the literature so far” [2]. Nearly two decades later, that is still close to true.
The pH Finding, and Why It Is the Most Practical Result Here
The single most actionable detail in the 2007 study is easy to skim past: permeability coefficients for the copper complexes increased as pH increased, and the authors identified both ligand structure and the pH of the formulation as factors that could hamper copper migration through the model membrane [1]. In other words, the same concentration of the same ingredient did not behave the same way at every pH in that system. This is one concrete, evidence-based reason why a copper peptide serum is not simply the sum of its percentage on the label, and why formulators treat pH as a design constraint rather than an afterthought. It is also the mechanistic thread connecting permeation to the practical layering questions people ask about combining copper peptides with low-pH exfoliating acids.
The Honest Limitation: These Are Model Membranes, Not People
Both diffusion-cell studies used artificial membranes engineered to behave like the stratum corneum. That is a legitimate and standard research approach, and it is much better evidence than mechanism-only speculation, but it is not the same as measuring how much GHK-Cu reaches the dermis of a living human face after a serum is applied. A liposome or liquid-crystal membrane in a diffusion cell does not have hair follicles, sweat glands, active desquamation, variable hydration, or the individual variation in barrier integrity that real skin has. Every number produced in that setting should be read as evidence that transport is chemically possible under controlled conditions, not as a measurement of what happens on your skin.
Where the Two 2025 Reviews Disagree
This is where the evidence stops giving a single clean answer, and it is worth showing rather than smoothing over. A 2025 review in Bioimpacts assessing GHK as a topical anti-wrinkle peptide concluded that GHK-Cu and the palmitoylated derivative are “effective and relatively skin permeable,” while noting that metal complexation and hydrophobic modification both increase permeability, and that further enhancement is achievable with cell-penetrating peptides or microneedle pretreatment [3]. A 2025 review in Molecules, examining the same delivery problem, characterised GHK-Cu as “a fairly hydrophilic compound with limited permeation through the lipophilic stratum corneum,” which is why the authors were interested in liposomal encapsulation as a workaround in the first place [4].
These are not contradictory findings so much as different thresholds for the word “enough.” Both groups agree the molecule is hydrophilic, that the barrier is lipophilic, that this is a real obstacle, and that delivery-enhancement strategies are an active area of work. They differ on whether the baseline permeation of a conventional serum is sufficient to matter. Anyone telling you this question is settled in either direction is ahead of the published evidence.
The Finding That Should Temper Everything
The same Bioimpacts review that reads most favourably on permeability also delivers the most sobering line in this literature: despite GHK-Cu and Pal-GHK being widely used in anti-wrinkle products on the cosmetic market, there is “a surprising absence of clinical studies using them,” and published information on their skin permeability, effectiveness, and physicochemical properties is insufficient [3]. That is a review author describing the state of the field, not a critic. The cellular evidence for what GHK-Cu does once it reaches a fibroblast is solid. The evidence for how much reaches a fibroblast through intact human skin, and what that produces in a measurable clinical outcome, is thin. Both things are true at once, and a realistic expectation for a copper peptide serum should be built on that combination rather than on the first half alone.
Frequently Asked Questions
Does GHK-Cu penetrate the skin or just sit on the surface?
Diffusion-cell studies using membranes modeling the stratum corneum found that GHK and its copper complexes do migrate across, unlike copper delivered without a peptide carrier [1] [2]. That is laboratory model-membrane evidence, not a measurement taken from human skin in vivo.
Why does the peptide part matter if copper is the active mineral?
In the 2007 diffusion-cell work, only the GHK tripeptide and its copper complexes crossed the model membrane [1]. The peptide functions as the transport form for copper rather than as inert packaging, which is the mechanistic argument for using GHK-Cu instead of a simple copper salt in a topical product.
Does the pH of my serum affect whether GHK-Cu absorbs?
In that model system, yes: permeability coefficients increased as pH increased, and formulation pH was named as a factor that could hamper copper migration [1]. That is a finding from an in vitro membrane model, so treat it as a reason formulation pH matters rather than as a specific target number to chase at home.
Is there proof GHK-Cu reaches the dermis in real human skin?
Not at the level people usually assume. The permeation evidence comes from artificial membrane models, and a 2025 review found a surprising absence of clinical studies on the products this ingredient is sold in, with insufficient published data on skin permeability and effectiveness [3].
Do “advanced delivery” claims on copper peptide products mean anything?
The underlying science is real: reviews identify liposomal encapsulation, palmitoylation, cell-penetrating peptides, and microneedle pretreatment as genuine permeation-enhancement strategies [3] [4]. Whether any specific product’s version of that has been tested is a separate question the label rarely answers.
References
- Mazurowska L, Mojski M. ESI-MS Study of the Mechanism of Glycyl-L-Histidyl-L-Lysine-Cu(II) Complex Transport Through Model Membrane of Stratum Corneum. Talanta (2007). PMID 19071668
- Mazurowska L, Mojski M. Biological Activities of Selected Peptides: Skin Penetration Ability of Copper Complexes With Peptides. Journal of Cosmetic Science (2008). PMID 18350235
- Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically Applied GHK as an Anti-Wrinkle Peptide: Advantages, Problems and Prospective. BioImpacts (2025). PMID 39963574
- Ogorek K, Nowak K, Wadych E, Ruzik L, Timerbaev AR, Matczuk M. Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes? Molecules (2025). PMID 39795193
- Maquart FX et al. Stimulation of Collagen Synthesis in Fibroblast Cultures by the Tripeptide-Copper Complex Glycyl-L-Histidyl-L-Lysine-Cu2+. FEBS Letters (1988). PMID 3169264
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical or dermatological advice. As an Amazon Associate we earn from qualifying purchases.
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
